Q
QuidelOrtho Corporation (QDEL)
NMS – Real Time Price. Currency in USD
11.12
+1.16 (11.65%)
At close: May 12, 2026, 4:00 PM EDT
11.07
-0.05 (-0.45%)
After-hours: May 12, 2026, 7:54 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
11.12
+1.16 (11.65%)
At close: May 12, 2026, 4:00 PM EDT
11.07
-0.05 (-0.45%)
After-hours: May 12, 2026, 7:54 PM EDT
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, to measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point of Care business unit provides instruments and tests to provide rapid results across a continuum of POC settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, Japan and Asia Pacific, and Latin America. The company was incorporated in 1979 and is headquartered in San Diego, California.
| Name | Position |
|---|---|
| Mr. Brian J. Blaser | President, CEO & Director |
| Mr. Bryan M. Hanson | Executive VP of Global Portfolio Management and Marketing |
| Mr. Erich Wolff | Executive Vice President of Strategy & Corporate Development |
| Mr. Jonathan P. Siegrist Ph.D. | Executive VP of Research & Development and CTO |
| Mr. Joseph M. Busky CPA | Chief Financial Officer |
| Mr. Nathaniel B. Sisitsky Esq. | Chief Legal Officer & Corporate Secretary |
| Date | Type | Document |
|---|---|---|
| 2026-05-11 | SD | qdelformsd2025.htm |
| 2026-05-06 | 10-Q | qdel-20260329.htm |
| 2026-05-05 | 8-K | qdel-20260505.htm |
| 2026-04-27 | DEFA14A | fy25defa14-a.htm |
| 2026-04-15 | 8-K | qdel-20260415.htm |
| 2026-03-24 | 8-K | d89902d8k.htm |
| 2026-02-19 | 10-K | qdel-20251228.htm |
| 2026-02-13 | 8-K | d97103d8k.htm |
| 2026-02-11 | 8-K | qdel-20260211.htm |
| 2026-02-05 | 8-K | d15685d8k.htm |
| Mr. Philip D. McLellan | Chief Operations Officer |
| Mr. Ronald Lee Bowman | Chief Human Resources Officer |
| Ms. Juliet C. Cunningham | Vice President of Investor Relations |
| Ms. Lisa S. Hayes | Vice President of Global Marketing & Corporate Communications |